Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer have?
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer has 126 citations in the OpenAlex counts ScholarIQ stores.
When was Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer published?
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer has 2024 year in the ScholarIQ index.
What is the open-access status of Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer?
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer?
The DOI for Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer is on the source record.
What is the PMID of Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer?
The PMID for Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer is on the source record.
What is the OpenAlex record for Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer?
The OpenAlex for Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer is on the source record.